Antiapoptotic role of endogenous nitric oxide in human melanoma cells

Cancer Research

Volumn 61, Issue 1, 2001, Pages 318-326

  Salvucci, Ombretta ^a   Carsana, Marilisa ^a   Bersani, Ilaria ^a   Tragni, Gabrina ^a   Anichini, Andrea ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGUANIDINE; INTERLEUKIN 1BETA CONVERTING ENZYME; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL CULTURE; CELL SURVIVAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MELANOMA; PRIORITY JOURNAL;

APOPTOSIS; CASPASE 1; CASPASE 3; CASPASES; CELL CYCLE; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, NEOPLASTIC; GUANIDINES; HUMANS; INTRACELLULAR MEMBRANES; JURKAT CELLS; MELANOCYTES; MELANOMA; MEMBRANE POTENTIALS; MITOCHONDRIA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0035132835     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. The chemoresistance of human malignant melanoma: An update
2. Escape of human solid tumors from T-cell recognition: Molecular mechanisms and functional significance
3. Determinants of tamoxifen sensitivity control the nature of the synergistic interaction between tamoxifen and cisplatin
4. Type 1 consensus interferon (CIFN) gene transfer into human melanoma cells up-regulates p53 and enhances cisplatin-induced apoptosis: Implications for new therapeutic strategies with IFN-α
5. Chemotherapy-induced apoptosis in melanoma cells is p53 dependent
6. Increase of cisplatin sensitivity by c-myc antisense oligo-deoxynucleotides in a human metastatic melanoma inherently resistant to cisplatin
7. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice
8. Activated N-ras contributes to the chemoresistance of human melanoma in severe combined immunodeficiency (SCID) mice by blocking apoptosis
9. Alterations of DNA repair in melanoma cell lines resistant to cisplatin, fotemustine, or etoposide
10. Tyrosinase-related protein 2 as a mediator of melanoma specific resistance to cis-diamminedichloroplatinum(II): Therapeutic implications
11. Inhibition of death receptor signals by cellular FLIP
12. FLIP prevents apoptosis induced by death receptors but not by perforin/granzyme B, chemotherapeutic drugs, and gamma irradiation
13. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
14. Immune escape of tumors in vivo by expression of cellular FLICE-inhibitory protein
15. Inhibition of homologue of Slimb (HOS) function sensitizes human melanoma cells for apoptosis
16. Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential
17. Progression-related expression of β3 integrin in melanomas and nevi
18. Integrin αvβ3 promotes M21 melanoma growth in human skin by regulating tumor cell survival
19. Expression and targeting of the apoptosis inhibitor, surviving in human melanoma
20. Expression of tyrosinase, TRP-1 and TRP-2 protects melanoma cells from ultraviolet B induced apoptosis
21. Nitric oxide suppresses apoptosis via interrupting caspase activation and mitochondrial dysfunction in cultured hepatocytes
22. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases
23. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels
24. The nitric oxide donors, azide and hydroxylamine, inhibit the programmed cell death of cytokine-deprived human eosinophils
25. Human NK cells express endothelial nitric oxide synthase, and nitric oxide protects them from activation-induced cell death by regulating expression of TNF-α
26. Activated murine macrophages induce apoptosis in tumor cells through nitric oxide-dependent or -independent mechanisms
27. Nitric oxide is an important mediator for tumoricidal activity in vivo
28. 1arrest and an increase of the cyclin-dependent kinase inhibitor p21WAFI/CIP1
29. Caspase activation is required for nitric oxide-mediated, CD95(APO-1/Fas)-dependent and independent apoptosis in human neoplastic lymphoid cells
30. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells
31. Nitric oxide-mediated apoptosis of K-1735 melanoma cells is associated with down-regulation of Bcl-2
32. Cytotoxic T cells directed to tumor antigens not expressed on normal melanocytes dominate HLA-A*0201-restricted immune repertoire to melanoma
33. Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions
34. An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions
35. Selective inhibition of the inducible nitric oxide synthase by aminoguanidine
36. Selective inhibition of inducible nitric oxide synthase inhibits tumor growth in vivo: Studies with 1400W, a novel inhibitor
37. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death
38. Nitric oxide and macrophage function
39. Non-enzymatic production of nitric oxide (NO) from NO synthase inhibitors
40. Apoptosis and cancer drug targeting
41. Caspases: The executioners of apoptosis
42. PIN: An associated protein inhibitor of neuronal nitric oxide synthase
43. A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK
44. mdm2: A bridge over two tumour suppressors, p53 and Rb
45. The MDM2 oncoprotein promotes apoptosis in p53-deficient human medullary thyroid carcinoma cells
46. Nitric oxide synthase activity is up-regulated in melanoma cell lines: A potential mechanism for metastasis formation
47. Fibronectin suppresses apoptosis in normal human melanocytes through an integrin-dependent mechanism
48. Molecular characterization of mitochondrial apoptosis-inducing factor
49. Mitochondria and apoptosis
50. Mitochondrial release of caspase-2 and -9 during the apoptotic process
51. BH14 domain of antiapoptotic Bc1-2 family members closes voltage dependent anion channel and inhibits apoptotic mitochondrial changes and cell death
52. Caspase-3-dependent cleavage of Bcl-2 promotes release of cytochrome c
53. Nitric oxide fully protects against UVA-induced apoptosis in tight correlation with Bcl-2 up-regulation
54. Induction of mitochondrial permeability transition and cytochrome c release in the absence of caspase activation is insufficient for effective apoptosis in human leukemia cells
55. Nitric oxide (NO) inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms
56. S-nitrosylation regulates apoptosis
57. Fas-induced caspase denitrosylation
58. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo
59. Nitric oxide reversibly inhibits seven members of the caspase family via S-nitrosylation
60. Nitric oxide inhibits c-Jun N-terminal kinase 2 (JNK) via S-nitrosylation
61. Expression of the neuronal isoform of nitric oxide synthase (nNOS) and its inhibitor, protein inhibitor of nNOS, in pigment cell lesions of the skin